The importance of histological patterns on PD-L1 staining heterogeneity: Should we use pattern-based approach for selecting tumor samples for PD-L1 testing in lung

被引:5
|
作者
Bulutay, Pinar [1 ]
Firat, Pinar [1 ]
Zeren, Handan [2 ]
Erus, Suat [3 ]
Tanju, Serhan [3 ]
Dilege, Sukru [3 ]
机构
[1] Koc Univ, Med Fac, Dept Pathol, Istanbul, Turkey
[2] Acibadem Univ, Med Fac, Dept Pathol, Istanbul, Turkey
[3] Koc Univ, Med Fac, Dept Thorac Surg, Istanbul, Turkey
关键词
PD-L1; lung cancer; immunotherapy; lung adenocarcinoma; IMMUNE CELLS; EXPRESSION; CANCER; IMMUNOHISTOCHEMISTRY; CLASSIFICATION; IMMUNOTHERAPY; RELIABILITY; ANTI-PD-1; LIGANDS;
D O I
10.3906/sag-2004-61
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Programmed death ligand-1 (PD-L1) is a predictive marker for immunotherapeutic agents. However, heterogeneous staining of PD-L1 can cause false-negative results. The aim of this study is to evaluate the importance of histological patterns on PD-L1 staining heterogeneity in lung adenocarcinomas (LAC). Materials and methods: PD-L1 immunohistochemistry (IHC) stain was performed to two different tissue cores of 128 LAC cases, and cut-off values are given for grouping the cases according to the percentage of staining (1%-10%, 11%-49%, 50%-100%). Staining rates between cores were compared and analyzed by their histological patterns. Also, the relation of the PD-L1 expression with the clinicopathological characteristics of the cases was analyzed. Results: Overall, PD-L1 expression was observed in 53 of 128 cases (41.4%, 1% cut-off), 23.5% of them were positive at 10% cut-off and 14.1% at 50% cut-off. PD-L1 expression was significantly related to the high grade micropapillary and solid patterns of adenocarcinomas (p:0.01). Staining cut-offs were mostly similar between cores (43/50, 86%) (k:0.843). However, 14% of them were positive only in one core (7 of 50). This false negativity was mostly related to the histological patterns. Conclusion: Our data reveal the heterogeneous staining of PD-L1 expression, also micropapillary and solid patterns show higher rates of PDL expression. Therewithal, these findings also highlight the importance of taking into consideration of histological patterns, when choosing a paraffin block for the PDL1.
引用
收藏
页码:204 / 213
页数:10
相关论文
共 50 条
  • [41] Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure
    Pathak, Ranjan
    Pharaon, Rebecca R.
    Mohanty, Atish
    Villaflor, Victoria M.
    Salgia, Ravi
    Massarelli, Erminia
    CANCERS, 2020, 12 (12) : 1 - 13
  • [42] The Impact of Tumor Heterogeneity on PD-L1 Status, using PD-L1 IHC 22C3 pharmDx on Multiple Human Cancer Tissues
    Ruvalcaba-Rodarte, Jim
    Hund, Stephanie
    Moquin, Deanna
    Ponce, Francisco
    Adams, Micki
    Morones, Amber
    Borgert, Kiera
    Kersch, Kris
    Kulangara, Karina
    Kalpakoff, Megan
    LABORATORY INVESTIGATION, 2023, 103 (03) : S671 - S672
  • [43] PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation
    Cree, Ian A.
    Booton, Richard
    Cane, Paul
    Gosney, John
    Ibrahim, Merdol
    Kerr, Keith
    Lal, Rohit
    Lewanski, Conrad
    Navani, Neal
    Nicholson, Andrew G.
    Nicolson, Marianne
    Summers, Yvonne
    HISTOPATHOLOGY, 2016, 69 (02) : 177 - 186
  • [44] Research progress of tumor targeted drug delivery based on PD-1/PD-L1
    Liu, Dongzhu
    Gao, Shan
    Zhai, Yujia
    Yang, Xiaoye
    Zhai, Guangxi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 616
  • [45] PTEN Loss and PD-L1 Expression of Different Histological Patterns of Prostate Cancer
    Kir, Gozde
    Cecikoglu, Gozde Ecem
    Olgun, Zeynep Cagla
    Kazan, Huseyin Ozgur
    Yildirim, Asif
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 229
  • [46] Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma
    Owen, Dwight
    Chu, Benjamin
    Lehman, Amy M.
    Annamalai, Lakshmanan
    Yearley, Jennifer H.
    Shilo, Konstantin
    Otterson, Gregory A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1204 - 1212
  • [47] PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer
    Baeza Mena, Sonia Margarita
    Centeno Clemente, Carmen Angela
    Andreo Garcia, Felipe
    Serra Mitja, Pere
    Tazi Mezalek, Rachid
    Mate Sanz, Jose Luis
    Martinez Barenys, Carlos
    Carcereny Costa, Enric
    Margeli Cervera, Victor
    Abad Capa, Jorge
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [48] Association of PD-L1 Expression with Histological Grade and Mutational Profile in Lung Adenocarcinoma
    Basu, Atreyee
    Narula, Navneet
    Simms, Anthony
    Shirsat, Hemlata
    Zhou, Fang
    Moreira, Andre
    LABORATORY INVESTIGATION, 2019, 99
  • [49] PD-L1 expression in paired non-small cell lung cancer tumor samples
    Kim, Jhingook
    Sorensen, Steffen Filskov
    Choi, Yoon-La
    Wang, Zhen
    Sun, Jong-Mu
    Choi, Hyejoo
    Georgsen, Jeanette Baehr
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Wu, Dianna Y.
    Meldgaard, Peter
    Zhou, Wei
    Hager, Henrik
    CANCER RESEARCH, 2015, 75
  • [50] Association of PD-L1 Expression with Histological Grade and Mutational Profile in Lung Adenocarcinoma
    Basu, Atreyee
    Narula, Navneet
    Simms, Anthony
    Shirsat, Hemlata
    Zhou, Fang
    Moreira, Andre
    MODERN PATHOLOGY, 2019, 32